Omeros Corporation
OMER
3,37 €
Share price
7.67%
Change (1 day)
-17.43%
Change (1 year)
Categories
Omeros Corporation (OMER) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €0.38 Billion
According to Omeros Corporation's latest financial reports the company's total liabilities are €0.38 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Omeros Corporation - Total liabilities on balance sheet (from 2008 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | €0.47 B | 34.89% |
| 2021-12-31 | €0.34 B | 42.33% |
| 2020-12-31 | €0.24 B | 11.74% |
| 2019-12-31 | €0.21 B | 28.11% |
| 2018-12-31 | €0.17 B | 72.62% |
| 2017-12-31 | €99.29 M | -0.27% |
| 2016-12-31 | €99.56 M | 44.71% |
| 2015-12-31 | €68.8 M | 56.44% |
| 2014-12-31 | €43.97 M | 73.93% |
| 2013-12-31 | €25.28 M | 1.03% |
| 2012-12-31 | €25.02 M | -0.1% |
| 2011-12-31 | €25.05 M | 32.06% |
| 2010-12-31 | €18.97 M | 43.68% |
| 2009-12-31 | €13.2 M | -83.64% |
| 2008-12-31 | €80.72 M | 21.38% |
| 2007-12-31 | €66.5 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Eterna Therapeutics ERNA | €9.43 M | -97.55% | 🇺🇸 USA |
 Genetic Technologies GENE | €2.49 M | -99.35% | 🇦🇺 Australia |
 Pfizer PFE | €100.60 B | 26,061.65% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €99.03 B | 25,654.04% | 🇺🇸 USA |